The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nano Biotechnology-Global Market Insights and Sales Trends 2025
Synopsis
The global Nano Biotechnology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nano Biotechnology in various end use industries. The expanding demands from the Pharmaceuticals, Medical Devices, Medical Research and Other, are propelling Nano Biotechnology market. 0-10 nm, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 10-100 nm segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nano Biotechnology market, driven by demand from China, the second largest economy with some signs of stabilising, the Nano Biotechnology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nano Biotechnology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nano Biotechnology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nano Biotechnology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nano Biotechnology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nano Biotechnology covered in this report include Aduro BioTech, Calando Pharmaceuticals, Biosante Phosphate Pharmaceuticals, Celgene Corporation, Elan Pharmaceuticals, Flamel Technologies, Nanophase Technologies, Sigma Aldrich Company and Dendritic Nanotechnologies, etc.
The global Nano Biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals
Global Nano Biotechnology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nano Biotechnology market, Segment by Type:
0-10 nm
10-100 nm
Global Nano Biotechnology market, by Application
Pharmaceuticals
Medical Devices
Medical Research
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nano Biotechnology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Nano Biotechnology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Nano Biotechnology in various end use industries. The expanding demands from the Pharmaceuticals, Medical Devices, Medical Research and Other, are propelling Nano Biotechnology market. 0-10 nm, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 10-100 nm segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Nano Biotechnology market, driven by demand from China, the second largest economy with some signs of stabilising, the Nano Biotechnology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nano Biotechnology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nano Biotechnology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nano Biotechnology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nano Biotechnology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nano Biotechnology covered in this report include Aduro BioTech, Calando Pharmaceuticals, Biosante Phosphate Pharmaceuticals, Celgene Corporation, Elan Pharmaceuticals, Flamel Technologies, Nanophase Technologies, Sigma Aldrich Company and Dendritic Nanotechnologies, etc.
The global Nano Biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Aduro BioTech
Calando Pharmaceuticals
Biosante Phosphate Pharmaceuticals
Celgene Corporation
Elan Pharmaceuticals
Flamel Technologies
Nanophase Technologies
Sigma Aldrich Company
Dendritic Nanotechnologies
SkyePharma Pharmaceuticals
Global Nano Biotechnology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nano Biotechnology market, Segment by Type:
0-10 nm
10-100 nm
Global Nano Biotechnology market, by Application
Pharmaceuticals
Medical Devices
Medical Research
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nano Biotechnology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nano Biotechnology
1.1 Nano Biotechnology Market Overview
1.1.1 Nano Biotechnology Product Scope
1.1.2 Nano Biotechnology Market Status and Outlook
1.2 Global Nano Biotechnology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nano Biotechnology Market Size by Region (2018-2029)
1.4 Global Nano Biotechnology Historic Market Size by Region (2018-2023)
1.5 Global Nano Biotechnology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nano Biotechnology Market Size (2018-2029)
1.6.1 North America Nano Biotechnology Market Size (2018-2029)
1.6.2 Europe Nano Biotechnology Market Size (2018-2029)
1.6.3 Asia-Pacific Nano Biotechnology Market Size (2018-2029)
1.6.4 Latin America Nano Biotechnology Market Size (2018-2029)
1.6.5 Middle East & Africa Nano Biotechnology Market Size (2018-2029)
2 Nano Biotechnology Market by Type
2.1 Introduction
2.1.1 0-10 nm
2.1.2 10-100 nm
2.2 Global Nano Biotechnology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nano Biotechnology Historic Market Size by Type (2018-2023)
2.2.2 Global Nano Biotechnology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nano Biotechnology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nano Biotechnology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nano Biotechnology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nano Biotechnology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nano Biotechnology Revenue Breakdown by Type (2018-2029)
3 Nano Biotechnology Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceuticals
3.1.2 Medical Devices
3.1.3 Medical Research
3.1.4 Other
3.2 Global Nano Biotechnology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nano Biotechnology Historic Market Size by Application (2018-2023)
3.2.2 Global Nano Biotechnology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nano Biotechnology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nano Biotechnology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nano Biotechnology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nano Biotechnology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nano Biotechnology Revenue Breakdown by Application (2018-2029)
4 Nano Biotechnology Competition Analysis by Players
4.1 Global Nano Biotechnology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nano Biotechnology as of 2022)
4.3 Date of Key Players Enter into Nano Biotechnology Market
4.4 Global Top Players Nano Biotechnology Headquarters and Area Served
4.5 Key Players Nano Biotechnology Product Solution and Service
4.6 Competitive Status
4.6.1 Nano Biotechnology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Aduro BioTech
5.1.1 Aduro BioTech Profile
5.1.2 Aduro BioTech Main Business
5.1.3 Aduro BioTech Nano Biotechnology Products, Services and Solutions
5.1.4 Aduro BioTech Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.1.5 Aduro BioTech Recent Developments
5.2 Calando Pharmaceuticals
5.2.1 Calando Pharmaceuticals Profile
5.2.2 Calando Pharmaceuticals Main Business
5.2.3 Calando Pharmaceuticals Nano Biotechnology Products, Services and Solutions
5.2.4 Calando Pharmaceuticals Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.2.5 Calando Pharmaceuticals Recent Developments
5.3 Biosante Phosphate Pharmaceuticals
5.3.1 Biosante Phosphate Pharmaceuticals Profile
5.3.2 Biosante Phosphate Pharmaceuticals Main Business
5.3.3 Biosante Phosphate Pharmaceuticals Nano Biotechnology Products, Services and Solutions
5.3.4 Biosante Phosphate Pharmaceuticals Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.3.5 Celgene Corporation Recent Developments
5.4 Celgene Corporation
5.4.1 Celgene Corporation Profile
5.4.2 Celgene Corporation Main Business
5.4.3 Celgene Corporation Nano Biotechnology Products, Services and Solutions
5.4.4 Celgene Corporation Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.4.5 Celgene Corporation Recent Developments
5.5 Elan Pharmaceuticals
5.5.1 Elan Pharmaceuticals Profile
5.5.2 Elan Pharmaceuticals Main Business
5.5.3 Elan Pharmaceuticals Nano Biotechnology Products, Services and Solutions
5.5.4 Elan Pharmaceuticals Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.5.5 Elan Pharmaceuticals Recent Developments
5.6 Flamel Technologies
5.6.1 Flamel Technologies Profile
5.6.2 Flamel Technologies Main Business
5.6.3 Flamel Technologies Nano Biotechnology Products, Services and Solutions
5.6.4 Flamel Technologies Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.6.5 Flamel Technologies Recent Developments
5.7 Nanophase Technologies
5.7.1 Nanophase Technologies Profile
5.7.2 Nanophase Technologies Main Business
5.7.3 Nanophase Technologies Nano Biotechnology Products, Services and Solutions
5.7.4 Nanophase Technologies Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.7.5 Nanophase Technologies Recent Developments
5.8 Sigma Aldrich Company
5.8.1 Sigma Aldrich Company Profile
5.8.2 Sigma Aldrich Company Main Business
5.8.3 Sigma Aldrich Company Nano Biotechnology Products, Services and Solutions
5.8.4 Sigma Aldrich Company Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.8.5 Sigma Aldrich Company Recent Developments
5.9 Dendritic Nanotechnologies
5.9.1 Dendritic Nanotechnologies Profile
5.9.2 Dendritic Nanotechnologies Main Business
5.9.3 Dendritic Nanotechnologies Nano Biotechnology Products, Services and Solutions
5.9.4 Dendritic Nanotechnologies Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.9.5 Dendritic Nanotechnologies Recent Developments
5.10 SkyePharma Pharmaceuticals
5.10.1 SkyePharma Pharmaceuticals Profile
5.10.2 SkyePharma Pharmaceuticals Main Business
5.10.3 SkyePharma Pharmaceuticals Nano Biotechnology Products, Services and Solutions
5.10.4 SkyePharma Pharmaceuticals Nano Biotechnology Revenue (US$ Million) & (2018-2023)
5.10.5 SkyePharma Pharmaceuticals Recent Developments
6 North America
6.1 North America Nano Biotechnology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nano Biotechnology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nano Biotechnology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nano Biotechnology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nano Biotechnology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nano Biotechnology Market Dynamics
11.1 Nano Biotechnology Industry Trends
11.2 Nano Biotechnology Market Drivers
11.3 Nano Biotechnology Market Challenges
11.4 Nano Biotechnology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
